A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs

References

• Bruni L, Albero G, Rowley J, Alemany L, Arbyn M, Giuliano AR, Markowitz LE, Broutet N, Taylor M. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet Global Health. 2023;11(9):e1345–10. doi:10.1016/S2214-109X(23)00305-4.
   PubMed Web of Science ®Google Scholar
• Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30:12–23. doi:10.1016/j.vaccine.2012.07.055.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guide to introducing HPV vaccine into national immunization programmes; 2016 [accessed 2023 Nov]. https://apps.who.int/iris/handle/10665/253123.
   Google Scholar
• Zhou L, Gu B, Wang J, Liu G, Zhang X. Human papillomavirus vaccination at the national and provincial levels in China: a cost-effectiveness analysis using the PRIME model. BMC Public Health. 2022;22(1):777. doi:10.1186/s12889-022-13056-5.
   PubMed Web of Science ®Google Scholar
• WHO HPV Vaccine Global Market Study. Technical document; 2022 Apr [accessed 2023 Nov]. https://www.who.int/publications/m/item/who-hpv-vaccine-global-market-study-april-2022.
   Google Scholar
• Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020 [accessed 2023 Nov]. https://www.who.int/publications/i/item/9789240014107.
   Google Scholar
• World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017–Recommendations. Vaccine. 2017;35(43):5753–5755. doi:10.1016/j.vaccine.2017.05.069.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Immunization data portal. Human Papillomavirus (HPV) vaccination coverage. [ accessed 2024 Feb]. https://immunizationdata.who.int/pages/coverage/hpv.html?CODE=Global&ANTIGEN=PRHPV1_M&YEAR=.
   Google Scholar
• Paul P, Fabio A. Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program. Vaccine. 2014;32(3):320–326. doi:10.1016/j.vaccine.2013.11.070.
   PubMed Web of Science ®Google Scholar
• Middleman A. School-located vaccination for adolescents: past, present, and future and implications for HPV vaccine delivery. Hum Vaccines Immunother. 2016;12(6):1599–1605. doi:10.1080/21645515.2016.1168953.
   PubMed Web of Science ®Google Scholar
• Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Burchett HED, LaMontagne DS, Watson-Jones D. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016. Papilloma Res. 2017;4:72–78. doi:10.1016/j.pvr.2017.09.001.
   PubMed Web of Science ®Google Scholar
• Nguyen-Huu N-H, Thilly N, Derrough T, Sdona E, Claudot F, Pulcini C, Agrinier N. Human papillomavirus vaccination coverage, policies, and practical implementation across Europe. Vaccine. 2020;38(6):1315–1331. doi:10.1016/j.vaccine.2019.11.081.
   PubMed Web of Science ®Google Scholar
• Dykens J, Peterson CE, Holt HK, Harper DM. Gender neutral HPV vaccination programs: reconsidering policies to expand cancer prevention globally. Front Public Health. 2023;11:1067299. doi:10.3389/fpubh.2023.1067299.
   PubMed Web of Science ®Google Scholar
• LaMontagne DS, Manangazira P, Marembo J, Chigodo C, Zvamashakwe C, Tshuma E, Marima E, Chindedza K, Ndlela E, Mooney J, et al. HPV vaccination coverage in three districts in Zimbabwe following national introduction of 0, 12 month schedule among 10 to 14 year old girls. Vaccine. 2022;40(Suppl 1):A58–A66. doi:10.1016/j.vaccine.2021.07.012.
   PubMedGoogle Scholar
• Molokwu J, Dwivedi A, Mallawaarachchi I, Hernandez A, Shokar N. Tiempo de vacunarte (time to get vaccinated): outcomes of an intervention to improve HPV vaccination rates in a predominantly hispanic community. Prev Med. 2019;121:115–120. doi:10.1016/j.ypmed.2019.02.004.
   PubMed Web of Science ®Google Scholar
• McClure CA, MacSwain MA, Morrison H, Sanford CJ. Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada. Vaccine. 2015;33(15):1786–1790. doi:10.1016/j.vaccine.2015.02.047.
   PubMed Web of Science ®Google Scholar
• Dorji T, Tshomo U, Phuntsho S, Tamang TD, Tshokey T, Baussano I, Franceschi S, Clifford G. Introduction of a national HPV vaccination program into Bhutan. Vaccine. 2015;33(31):3726–3730. doi:10.1016/j.vaccine.2015.05.078.
   PubMed Web of Science ®Google Scholar
• Lee LY, Garland SM. Human papillomavirus vaccination: the population impact. F1000Res. 2017;6:866. doi:10.12688/f1000research.10691.1.
   PubMedGoogle Scholar
• Hansen PR, Schmidtblaicher M, Brewer NT. Resilience of HPV vaccine uptake in Denmark: decline and recovery. Vaccine. 2020;38(7):1842–1848. doi:10.1016/j.vaccine.2019.12.019.
   PubMed Web of Science ®Google Scholar
• Bigaard J, Franceschi S. Vaccination against HPV: boosting coverage and tackling misinformation. Mol Oncol. 2021;15(3):770–778. doi:10.1002/1878-0261.12808.
   PubMed Web of Science ®Google Scholar
• Potts A, Sinka K, Love J, Gordon R, McLean S, Malcolm W, Ross D, Donaghy M. High uptake of HPV immunisation in Scotland – perspectives on maximising uptake. EuroSurveillance. 2013;18(39):20593. doi:10.2807/1560-7917.es2013.18.39.20593.
   Web of Science ®Google Scholar
• Gatera M, Bhatt S, Ngabo F, Utamuliza M, Sibomana H, Karema C, Mugeni C, Nutt CT, Nsanzimana S, Wagner CM, et al. Successive introduction of four new vaccines in Rwanda: high coverage and rapid scale up of Rwanda’s expanded immunization program from 2009 to 2013. Vaccine. 2016;34(29):3420–3426. doi:10.1016/j.vaccine.2015.11.076.
   PubMed Web of Science ®Google Scholar
• Muhamad NA, Buang SN, Jaafar S, Jais R, Tan PS, Mustapha N, Lodz NA, Aris T, Sulaiman LH, Murad S, et al. Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme. BMC Public Health. 2018;18(1):1402. doi:10.1186/s12889-018-6316-6.
   PubMed Web of Science ®Google Scholar
• Acampora A, Grossi A, Barbara A, Colamesta V, Causio FA, Calabro GE, Boccia S, de Waure C. Increasing HPV vaccination uptake among adolescents: a systematic review. Int J Environ Res Public Health. 2020;17(21):7997. doi:10.3390/ijerph17217997.
   PubMed Web of Science ®Google Scholar
• Chaw LL, Lim STW, Md Yussof SR. Human papillomavirus vaccine coverage among female students in Brunei Darussalam: results from the first 4 years of the national school-based vaccination programme. Heliyon. 2019;5(10):e02588. doi:10.1016/j.heliyon.2019.e02588.
   PubMed Web of Science ®Google Scholar
• Giambi C, Del Manso M, D’Ancona F, De Mei B, Giovannelli I, Cattaneo C, Possenti V, Declich S. Actions improving HPV vaccination uptake – results from a national survey in Italy. Vaccine. 2015;33(21):2425–2431. doi:10.1016/j.vaccine.2015.04.007.
   PubMed Web of Science ®Google Scholar
• Jeannot E, Petignat P, Sudre P. Successful implementation and results of an HPV vaccination program in Geneva Canton, Switzerland. Public Health Rep. 2015;130(3):202–206. doi:10.1177/003335491513000306.
   PubMed Web of Science ®Google Scholar
• Mphuru A, Li AJ, Kyesi F, Mwengee W, Mazige F, Nshunju R, Shayo B, Giattas MR, Loharikar A, Lyimo D, et al. National introduction of human papillomavirus (HPV) vaccine in Tanzania: programmatic decision-making and implementation. Vaccine. 2022;40(Suppl 1):A2–A9. doi:10.1016/j.vaccine.2021.04.025.
   PubMedGoogle Scholar
• Ahmed D, VanderEnde K, Harvey P, Bhatnagar P, Kaur N, Roy S, Singh N, Denzongpa P, Haldar P, Loharikar A. Human papillomavirus (HPV) vaccine introduction in Sikkim state: best practices from the first statewide multiple-age cohort HPV vaccine introduction in India–2018–2019. Vaccine. 2022;40(Suppl 1):A17–A25. doi:10.1016/j.vaccine.2021.07.024.
   PubMedGoogle Scholar
• OECD. Cancer screening and prevention in Chile. OECD reviews of public health: Chile a healthier tomorrow [Internet]. OECD iLibrary: oecd-ilibrary.org [168]; 2019 Jan 11 [accessed 2023 Nov]. https://www.oecd-ilibrary.org/sites/9789264309593-7-en/index.html?itemId=/content/component/9789264309593-7-en.
   Google Scholar
• Rehn M, Uhnoo I, Kuhlmann-Berenzon S, Wallensten A, Sparen P, Netterlid E, Grce M. Highest vaccine uptake after school-based delivery - a county-level evaluation of the implementation strategies for HPV catch-up vaccination in Sweden. PLoS One. 2016;11(3):e0149857. doi:10.1371/journal.pone.0149857.
   PubMed Web of Science ®Google Scholar
• Vanderpool RC, Breheny PJ, Tiller PA, Huckelby CA, Edwards AD, Upchurch KD, Phillips CA, Weyman CF. Implementation and evaluation of a school-based human papillomavirus vaccination program in rural Kentucky. Am J Prev Med. 2015;49(2):317–323. doi:10.1016/j.amepre.2015.05.001.
   PubMed Web of Science ®Google Scholar
• Kaul S, Do TQN, Hsu E, Schmeler KM, Montealegre JR, Rodriguez AM. School-based human papillomavirus vaccination program for increasing vaccine uptake in an underserved area in Texas. Papilloma Res. 2019;8:100189. doi:10.1016/j.pvr.2019.100189.
   PubMed Web of Science ®Google Scholar
• PAHO. Promoting immunization equity in the Americas; intersectoral collaboration, civil society participation, and community engagement; 2021 [accessed 2023 Nov]. https://www.paho.org/en/documents/promoting-immunization-equity-americas-intersectoral-collaboration-civil-society.
   Google Scholar
• Murray H, Corcoran B, O’Meara M. Introducing human papillomavirus (HPV) vaccination programme: the first year. Irish J Med Sci. 2012;5:S125–S126. doi:10.1007/s11845-012-0837-2
   Google Scholar
• Vollrath K, Thul S, Holcombe J. Meaningful methods for increasing human papillomavirus vaccination rates: an integrative literature review. J Pediatr Health Care. 2018;32(2):119–132. doi:10.1016/j.pedhc.2017.07.005.
   PubMed Web of Science ®Google Scholar
• Jeanne M, Eve S, Pasquier J, Blaizot X, Turck M, Raginel T. Human papillomaviruses vaccination: vaccine intentions of parents of children aged 10 to 11s in Normandy schools after an information campaign during the 2015–2016 school year. Presse Med. 2019;48(12):e369–e381. doi:10.1016/j.lpm.2019.10.001.
   PubMed Web of Science ®Google Scholar
• Parra-Medina D, Morales-Campos DY, Mojica C, Ramirez AG. Promotora Outreach, education and navigation support for HPV vaccination to Hispanic women with unvaccinated daughters. J Canc Educ. 2015;30(2):353–359. doi:10.1007/s13187-014-0680-4.
   PubMed Web of Science ®Google Scholar
• Balistreri JJ, Schulz C, Barry-Weers AM, Weese JL. A collaborative program for educating urban youth about HPV risk and cancer prevention. J Clin Oncol. 2018;36(30 Suppl):169. doi:10.1200/JCO.2018.36.30_suppl.169.
   Web of Science ®Google Scholar
• Walling EB, Benzoni N, Dornfeld J, Bhandari R, Sisk BA, Garbutt J, Colditz G, Interventions to improve HPV vaccine uptake: a systematic review. Pediatrics. 2016;138(1):e20153863. doi:10.1542/peds.2015-3863.
   PubMed Web of Science ®Google Scholar
• Zimet GD, Klein JK, Agadi V, Hu C, Jaramillo A. Digitally targeted messaging boosts adolescent vaccine administrations at the point of care. J Adolesc Health. 2020;66(2):S6–S7. doi:10.1016/j.jadohealth.2019.11.015.
   PubMed Web of Science ®Google Scholar
• Riviere C, Bell T, Cadot Y, Perodin C, Charles B, Bertil C, Cheung J, Bane S, Cheung HC, Pape JW, et al. Success of community approach to HPV vaccination in school-based and non-school-based settings in Haiti. PLoS One. 2021;16(6):e0252310. doi:10.1371/journal.pone.0252310.
   PubMed Web of Science ®Google Scholar
• Choi N, Curtis CR, Loharikar A, Fricchione M, Jones E, Balzer E, Liu Y, Levin M, Chavez-Torres M, Morita J, et al. Successful use of interventions in combination to improve human papillomavirus vaccination coverage rates among adolescents—Chicago, 2013 to 2015. Acad Pediatr. 2018;18(2):S93–S100. doi:10.1016/j.acap.2017.09.016.
   PubMed Web of Science ®Google Scholar
• Teixeira JC, Vianna MSC, Vale DB, Arbore DM, Perini THW, Couto TJT, Neto JP, Zeferino LC. School-based HPV vaccination: the challenges in a Brazilian initiative. Rev Bras Ginecol Obstet. 2021;43(12):926–931. doi:10.1055/s-0041-1740279.
   PubMedGoogle Scholar
• Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, Ngabo F. Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme. Bull World Health Organ. 2012;90(8):623–628. doi:10.2471/BLT.11.097253.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Shimizu Y, Netsu S, Hanley S, Konno R. High HPV vaccination uptake rates for adolescent girls after regional governmental funding in Shiki City, Japan. Vaccine. 2012;30(37):5547–5550. doi:10.1016/j.vaccine.2012.06.038.
   PubMed Web of Science ®Google Scholar
• Chung RJ, Walter EB, Kemper AR, Dayton A. Keen on teen vaccines: improvement of adolescent vaccine coverage in rural North Carolina. J Adolesc Health. 2015;56(5):S14–S16. doi:10.1016/j.jadohealth.2014.10.272.
   PubMed Web of Science ®Google Scholar
• Newcomer SR, Caringi J, Jones B, Coyle E, Schehl T, Daley MF. A mixed-methods analysis of barriers to and facilitators of human papillomavirus vaccination among adolescents in Montana. Public Health Rep. 2020;135(6):842–850. doi:10.1177/0033354920954512.
   PubMed Web of Science ®Google Scholar
• Washburn T, Devi Wold A, Raymond P, Duggan-Ball S, Marceau K, Beardsworth A. Current initiatives to protect Rhode Island adolescents through increasing HPV vaccination. Hum Vaccines Immunother. 2016;12(6):1633–1638. doi:10.1080/21645515.2016.1161460.
   PubMed Web of Science ®Google Scholar
• Eisenhauer L, Hansen BR, Pandian V. Strategies to improve human papillomavirus vaccination rates among adolescents in family practice settings in the United States: a systematic review. J Clin Nurs. 2021;30(3–4):341–356. doi:10.1111/jocn.15579.
   PubMed Web of Science ®Google Scholar
• Suryadevara M, Bonville CA, Cibula DA, Domachowske JB. Multi-component cancer prevention awareness program to improve adolescent HPV vaccine uptake. Hum Vaccines Immunother. 2021;17(4):1052–1058. doi:10.1080/21645515.2020.1812316.
   PubMed Web of Science ®Google Scholar
• Wallace-Brodeur R, Li R, Davis W, Humiston S, Albertin C, Szilagyi PG, Rand CM. A quality improvement collaborative to increase human papillomavirus vaccination rates in local health department clinics. Prev Med. 2020;139:106235. doi:10.1016/j.ypmed.2020.106235.
   PubMed Web of Science ®Google Scholar
• Conversano M, Russo C, Battista T, Caputi G, Desiante F, Giorgino A. Organizational models. Italian J Pediatr Conf. 2018;44(Supplement 3). doi:10.1186/s13052-018-0581-y.
   Google Scholar
• Das JK, Salam RA, Arshad A, Lassi ZS, Bhutta ZA. Systematic review and meta-analysis of interventions to improve access and coverage of adolescent immunizations. J Adolesc Health. 2016;59(4):S40–S48. doi:10.1016/j.jadohealth.2016.07.005.
   PubMed Web of Science ®Google Scholar
• Groom HC, Irving SA, Caldwell J, Larsen R, Beaudrault S, Luther LM, Naleway AL. Implementing a multipartner HPV vaccination assessment and feedback intervention in an integrated health system. J Public Health Manag Pract. 2017;23(6):589–592. doi:10.1097/PHH.0000000000000562.
   PubMed Web of Science ®Google Scholar
• McLean HQ, VanWormer JJ, Chow BDW, Birchmeier B, Vickers E, DeVries E, Meyer J, Moore J, McNeil MM, Stokley S, et al. Improving human papillomavirus vaccine use in an integrated health system: impact of a provider and staff intervention. J Adolesc Health. 2017;61(2):252–258. doi:10.1016/j.jadohealth.2017.02.019.
   PubMed Web of Science ®Google Scholar
• Sabzghabaei NR, Alton KA, Szpunar SM. Pediatric physicians-in-training can impact HPV vaccine uptake: a quality improvement study. Pediatrics. 2016;141(1):156. doi:10.1542/peds.141.1MA2.156.
   Google Scholar
• Whelan NW, Steenbeek A, Martin-Misener R, Scott J, Smith B, D’Angelo-Scott H. Engaging parents and schools improves uptake of the human papillomavirus (HPV) vaccine: examining the role of the public health nurse. Vaccine. 2014;32(36):4665–4671. doi:10.1016/j.vaccine.2014.06.026.
   PubMed Web of Science ®Google Scholar
• Wang J, Ploner A, Sparen P, Lepp T, Roth A, Arnheim-Dahlstrom L, Sundström K. Mode of HPV vaccination delivery and equity in vaccine uptake: a nationwide cohort study. Prev Med. 2019;120:26–33. doi:10.1016/j.ypmed.2018.12.014.
   PubMed Web of Science ®Google Scholar
• Tsu VD, LaMontagne DS, Atuhebwe P, Bloem PN, Ndiaye C. National implementation of HPV vaccination programs in low-resource countries: lessons, challenges, and future prospects. Prev Med. 2021;144:106335. doi:10.1016/j.ypmed.2020.106335.
   PubMed Web of Science ®Google Scholar
• Hopkins TG, Wood N. Female human papillomavirus (HPV) vaccination: global uptake and the impact of attitudes. Vaccine. 2013;31(13):1673–1679. doi:10.1016/j.vaccine.2013.01.028.
   PubMed Web of Science ®Google Scholar
• Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Griffiths UK, Feletto M, Burchett HED, LaMontage DS, Watson-Jones D. Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries. PLoS One. 2017;12(6):e0177773. doi:10.1371/journal.pone.0177773.
   PubMed Web of Science ®Google Scholar
• Brotherton JML, Bloem PN. Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage. Best Pract Res Clin Obstet Gynaecol. 2018;47:42–58. doi:10.1016/j.bpobgyn.2017.08.010.
   PubMed Web of Science ®Google Scholar
• Brotherton JML, Zuber PLF, Bloem PJN. Primary prevention of HPV through vaccination: update on the current global status. Curr Obstet Gynecol Rep. 2016;5(3):210–224. doi:10.1007/s13669-016-0165-z.
   Google Scholar
• Lefevere E, Theeten H, Hens N, De Smet F, Top G, Van Damme P. From non school-based, co-payment to school-based, free human papillomavirus vaccination in Flanders (Belgium): a retrospective cohort study describing vaccination coverage, age-specific coverage and socio-economic inequalities. Vaccine. 2015;33(39):5188–5195. doi:10.1016/j.vaccine.2015.07.088.
   PubMed Web of Science ®Google Scholar
• Skinner SRDC, Brotherton JML. HPV world the newsletter on HPV. Australia’s national HPV vaccination program. HPV world the newsletter on HPV; 2022 [accessed 2023 Nov]. https://www.hpvworld.com/articles/australia-s-national-hpv-vaccination-program/.
   Google Scholar
• Hayes KA, Entzel P, Berger W, Caskey RN, Shlay JC, Stubbs BW, Smith JS, Brewer NT. Early lessons learned from extramural school programs that offer HPV vaccine. J Sch Health. 2013;83(2):119–126. doi:10.1111/josh.12007.
   PubMed Web of Science ®Google Scholar
• Wilson S, Lim G, Seo C, McIntyre M, Fediurek J, Deeks S. 27. School-based vaccination programs in Ontario: vaccine coverage and non-medical exemptions. Paediatr Child Health (Oxford). 2014;19(6):e45. doi:10.1093/pch/19.6.e35-27.
   Google Scholar
• Wilson SE, Harris T, Sethi P, Fediurek J, Macdonald L, Deeks SL. Coverage from Ontario, Canada’s school-based HPV vaccine program: the first three years. Vaccine. 2013;31(5):757–762. doi:10.1016/j.vaccine.2012.11.090.
   PubMed Web of Science ®Google Scholar
• Brotherton JM, Murray SL, Hall MA, Andrewartha LK, Banks CA, Meijer D, Pitcher HC, Scully MM, Molchanoff L. Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. Med J Aust. 2013;199(9):614–617. doi:10.5694/mja13.10272.
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, Brotherton JML. Human papillomavirus vaccine introduction – the first five years. Vaccine. 2012;30(Suppl 5):F139–F148. doi:10.1016/j.vaccine.2012.05.039.
   PubMed Web of Science ®Google Scholar
• Ludwikowska KM, Biela M, Szenborn L. HPV vaccine acceptance and hesitancy – lessons learned during 8 years of regional HPV prophylaxis program in Wroclaw, Poland. Eur J Cancer Prev. 2020;29(4):346–349. doi:10.1097/CEJ.0000000000000556.
   PubMed Web of Science ®Google Scholar
• Owsianka B, Ganczak M. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide. Przegl Epidemiol. 2015;69(1):53–58,151–155.
   Google Scholar
• Perkins RB, Foley S, Hassan A, Jansen E, Preiss S, Isher-Witt J, Fisher-Borne M. Impact of a multilevel quality improvement intervention using national partnerships on human papillomavirus vaccination rates. Acad Pediatr. 2021;21(7):1134–1141. doi:10.1016/j.acap.2021.05.018.
   PubMed Web of Science ®Google Scholar
• Colzani EJK, Johnson H, Pastore CL. Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma. Euro Surveill. 2021;26(50):2001659. doi:10.2807/1560-7917.ES.2021.26.50.2001659.
   PubMedGoogle Scholar
• Ladner J, Besson MH, Hampshire R, Tapert L, Chirenje M, Saba J. Assessment of eight HPV vaccination programs implemented in lowest income countries. BMC Public Health. 2012;12(1):370. doi:10.1186/1471-2458-12-370.
   PubMedGoogle Scholar
• Ladner J, Besson MH, Rodrigues M, Audureau E, Saba J. Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009–2013. BMC Public Health. 2014;14(1):670. doi:10.1186/1471-2458-14-670.
   PubMedGoogle Scholar
• Nguyen-Huu N-H, Thilly N, Derrough T, Sdona E, Claudot F, Pulcini C, Agrinier N; HPV Policy Working Group. P2170 Human papillomavirus vaccination coverage and policies across 31 EU/EEa countries. 28th ECCMID – European Congress of Clinical Microbiology and Infectious Diseases; 2018 Apr 14–21; Madrid, Spain [accessed 2023 Nov]. https://2018.eccmid.org/.
   Google Scholar
• Trogdon JG, Shafer PR, Shah PD, Calo WA. Are state laws granting pharmacists authority to vaccinate associated with HPV vaccination rates among adolescents? Vaccine. 2016;34(38):4514–4519. doi:10.1016/j.vaccine.2016.07.056.
   PubMed Web of Science ®Google Scholar
• Amponsah-Dacosta E, Blose N, Nkwinika VV, Chepkurui V. Human papillomavirus vaccination in South Africa: programmatic challenges and opportunities for integration with other adolescent health services? Front Public Health. 2022;10:799984. doi:10.3389/fpubh.2022.799984.
   PubMed Web of Science ®Google Scholar
• Black E, Richmond R. Prevention of cervical cancer in Sub-Saharan Africa: the advantages and challenges of HPV vaccination. Vaccines (Basel). 2018;6(3):61. doi:10.3390/vaccines6030061.
   PubMed Web of Science ®Google Scholar
• Perez S, Zimet GD, Tatar O, Stupiansky NW, Fisher WA, Rosberger Z. Human papillomavirus vaccines: successes and future challenges. Drugs. 2018;78(14):1385–1396. doi:10.1007/s40265-018-0975-6.
   PubMed Web of Science ®Google Scholar
• Buggy D. After a sharp decline in HPV vaccine rates from 87% to 50%, Irish health experts, politicians and NGOs joined forces to turn the tide, helping to increase vaccination by 11%. This is how we did it. J Global Oncol. 2018;4(Supplement 2):145s. doi:10.1200/jgo.18.36000.
   Google Scholar
• Jacobs-Wingo JL, Jim CC, Groom AV. Human papillomavirus vaccine uptake: increase for American Indian adolescents, 2013–2015. Am J Prev Med. 2017;53(2):162–168. doi:10.1016/j.amepre.2017.01.024.
   PubMed Web of Science ®Google Scholar
• Paterson P, Mounier-Jack S, Saliba V, Yarwood J, White J, Ramsay M, Chantler T. Strengthening HPV vaccination delivery: findings from a qualitative service evaluation of the adolescent girls’ HPV vaccination programme in England. J Public Health (Oxf). 2021;43(1):189–196. doi:10.1093/pubmed/fdz061.
   PubMed Web of Science ®Google Scholar
• Fava JP, Colleran J, Bignasci F, Cha R, Kilgore PE. Adolescent human papillomavirus vaccination in the United States: opportunities for integrating pharmacies into the immunization neighborhood. Hum Vaccin Immunother. 2017;13(8):1844–1855. doi:10.1080/21645515.2017.1325980.
   PubMed Web of Science ®Google Scholar
• Bonanni P, Faivre P, Lopalco PL, Joura EA, Bergroth T, Varga S, Gemayel N, Drury R. The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018–2019). Expert Rev Vaccines. 2020;19(11):1073–1083. doi:10.1080/14760584.2020.1858057.
   PubMed Web of Science ®Google Scholar
• Fujiwara H, Takei Y, Ishikawa Y, Saga Y, Machida S, Taneichi A, Suzuki M. Community-based interventions to improve HPV vaccination coverage among 13- to 15-year-old females: measures implemented by local governments in Japan. PLoS One. 2013;8(12):e84126. doi:10.1371/journal.pone.0084126.
   PubMed Web of Science ®Google Scholar
• Hense S, Hillebrand K, Horn J, Mikolajczyk R, Schulze-Rath R, Garbe E. HPV vaccine uptake after introduction of the vaccine in Germany: an analysis of administrative data. Hum Vaccines Immunother. 2014;10(6):1729–1733. doi:10.4161/hv.28450.
   PubMed Web of Science ®Google Scholar
• Clave Llavall A, de Wildt G, Meza G, Tattsbridge J, Jones L, Evans WD. Nurses’ and teachers’ perceived barriers and facilitators to the uptake of the human papilloma virus (HPV) vaccination program in Iquitos, Peru: a qualitative study. – One. 2021;16(7):e0255218. doi:10.1371/journal.pone.0255218.
   PubMed Web of Science ®Google Scholar
• Hull B, Dey A, Menzies R, McIntyre P. Annual immunisation coverage report, 2010. Commun Dis Intell Q Rep. 2013;37(1):E21–E39. PMID: 23692156.
   PubMedGoogle Scholar
• Hull BP, Dey A, Menzies RI, Brotherton JM, McIntyre PB. Immunisation coverage, 2012. Commun Dis Intell Q Rep. 2014;38(3):E208–E231. PMID: 25391407.
   PubMedGoogle Scholar
• Cabrnochova HCR, Dusek L. Proočkovanost u vybraných preventabilních nákaz z dat národního zdravotnického informačního systému (NZIS). Vakcinologie. 2019;13:142–148.
   Google Scholar
• Ruffin MT, Plegue MA, Rockwell PG, Young AP, Patel DA, Yeazel MW. Impact of an electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion. J Am Board Fam Med. 2015;28(3):324–333. doi:10.3122/jabfm.2015.03.140082.
   PubMed Web of Science ®Google Scholar
• Goleman MJ, Dolce M, Morack J. Quality improvement initiative to improve human papillomavirus vaccine initiation at 9 years of age. Acad Pediatr. 2018;18(7):769–775. doi:10.1016/j.acap.2018.05.005.
   PubMed Web of Science ®Google Scholar
• Moss JL, Reiter PL, Truong YK, Rimer BK, Brewer NT. School entry requirements and coverage of nontargeted adolescent vaccines. Pediatrics. 2016;138(6):e20161414. doi:10.1542/peds.2016-1414.
   PubMed Web of Science ®Google Scholar
• Moss JL, Reiter PL, Rimer BK, Brewer NT. Collaborative patient-provider communication and uptake of adolescent vaccines. Social Sci Med. 2016;159:100–107. doi:10.1016/j.socscimed.2016.04.030.
   PubMed Web of Science ®Google Scholar
• Farmar ALM, Love-Osborne K, Chichester K, Breslin K, Bronkan K, Hambidge SJ. Achieving high adolescent HPV vaccination coverage. Pediatrics. 2016;138(5):e20152653. doi:10.1542/peds.2015-2653.
   PubMed Web of Science ®Google Scholar
• Hull BP, Dey A, Menzies RI, Brotherton JM, McIntyre PB. Immunisation coverage annual report, 2011. Commun Dis Intell Q Rep. 2013;37(4):E291–E312. PMID: 24882234.
   PubMedGoogle Scholar
• Boyce T, Gudorf A, de Kat C, Muscat M, Butler R, Habersaat KB. Towards equity in immunisation. Eurosurveillance. 2019;24(2):1800204. doi:10.2807/1560-7917.ES.2019.24.2.1800204.
   Web of Science ®Google Scholar
• Desiante F, Russo C, Giorgino A, Caputi G, Battista T, Cipriani R, Conversano M. Universal proposal strategies of anti-HPV vaccination for adolescents: comparative analysis between school-based and clinic immunization programs. J Prev Med Hyg. 2017;58(3):E225–E230. PMID: 29123369.
   PubMedGoogle Scholar
• Vorsters A, Bonanni P, Maltezou HC, Yarwood J, Brewer NT, Bosch FX, Hanley S, Cameron R, Franco EL, Arbyn M, et al. The role of healthcare providers in HPV vaccination programs – a meeting report. Papilloma Res. 2019;8:100183. doi:10.1016/j.pvr.2019.100183.
   PubMed Web of Science ®Google Scholar
• Elam-Evans LD, Yankey D, Jeyarajah J, Singleton JA, Curtis RC, MacNeil J, Hariri S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years--United States, 2013. Morb Mortal Wkly Rep. 2014;63(29):625–633. PMID: 25055186.
   PubMed Web of Science ®Google Scholar
• Crocker-Buque T, Edelstein M, Mounier-Jack S. Interventions to reduce inequalities in vaccine uptake in children and adolescents aged <19 years: a systematic review. J Epidemiol Community Health. 2017;71(1):87–97. doi:10.1136/jech-2016-207572.
   PubMed Web of Science ®Google Scholar
• Kabakama S, Gallagher KE, Howard N, Mounier-Jack S, Burchett HE, Griffiths UK, Feletto M, LaMontagne DS, Watson-Jones D. Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries. BMC Public Health. 2016;16(1):834. doi:10.1186/s12889-016-3517-8.
   PubMedGoogle Scholar
• Martakis K, Alexander D, Schloemer T, Blair M, Rigby M, Schroder-Back P. Human papillomavirus vaccination and respect for children’s developing autonomy: results from a European Union wide study. J Child Health Care. 2019;23(3):343–357. doi:10.1177/1367493519852476.
   PubMed Web of Science ®Google Scholar
• Immunization Agenda 2030. Core principle annex: partnerships; 2020 [accessed 2023 Nov]. https://www.immunizationagenda2030.org/images/documents/BLS20116_IA_Global_strategy_document_Core_Principles_001_partnership_001.pdf.
   Google Scholar
• Saidatul Buang and colleagues report on collaborative efforts to introduce HPV vaccination in Malaysia and increase coverage. Human papillomavirus immunisation of adolescent girls: improving coverage through multisectoral collaboration in Malaysia. BMJ: first published as 10.1136/bmj.k4602; 2018 Dec 7 [accessed 2023 Nov]. https://www.bmj.com/content/bmj/363/bmj.k4602.full.pdf.
   Google Scholar
• Nissen M, Kerkvliet JL, Polkinghorn A, Pugsley L. Increasing rates of human papillomavirus vaccination in family practice: a quality improvement project. S D Med. 2019;72:354–360.
   PubMedGoogle Scholar
• Head KJ, Biederman E, Sturm LA, Zimet GD. A retrospective and prospective look at strategies to increase adolescent HPV vaccine uptake in the United States. Hum Vaccines Immunother. 2018;14(7):1626–1635. doi:10.1080/21645515.2018.1430539.
   PubMed Web of Science ®Google Scholar